Covista Inc. (CVSA) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Covista Inc. (CVSA) Consumer Business Overview

Covista Inc., formerly Adtalem Global Education, is a consumer cyclical company providing post-secondary education through its Chamberlain, Walden, and Medical and Veterinary segments. With a market capitalization of $4.21B and a P/E ratio of 16.37, Covista focuses on delivering degree and non-degree programs in nursing, health professions, and online education.

What Is the Investment Thesis for CVSA?

With a market capitalization of $4.21B and a profit margin of 13.4%, the company demonstrates financial stability. Key value drivers include the increasing demand for skilled healthcare professionals and the growing adoption of online education. The company's beta of 0.73 suggests lower volatility compared to the broader market. Growth catalysts include expanding program offerings and strategic partnerships. Potential risks include regulatory changes in the education sector and increased competition from other online education providers. Investors should monitor Covista's ability to maintain its gross margin of 57.4% and adapt to evolving student needs.

Based on FMP financials and quantitative analysis

CVSA Key Highlights

Market capitalization of $4.21B, reflecting substantial investor confidence in Covista's market position.

• P/E ratio of 16.37, indicating a reasonable valuation relative to earnings.
• Profit margin of 13.4%, demonstrating efficient operations and profitability.
• Gross margin of 57.4%, highlighting the company's ability to maintain pricing power and manage costs effectively.
• Beta of 0.73, suggesting lower volatility compared to the overall market, making it a potentially stable investment.

Who Are CVSA's Competitors?

CVSA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CVSA's Key Strengths?

Strong brand reputation in nursing and healthcare education.

• Extensive network of healthcare partners.
• Focus on high-demand fields.
• Established online education platform.

What Are CVSA's Weaknesses?

Dependence on regulatory approvals and accreditation.

• Exposure to economic cycles and student enrollment trends.
• Competition from other online education providers.
• Potential for negative publicity related to student outcomes.

What Could Drive CVSA Stock Higher?

CVSA catalyst: Launch of new online programs in emerging fields such as data science and artificial intelligence (Q4 2026).

• Strategic partnerships with leading healthcare institutions to provide clinical experience and job placement opportunities.
• Investment in innovative learning technologies to enhance the student experience.
• Geographic expansion into emerging markets with a growing demand for higher education (2027).

What Are the Key Risks for CVSA?

Changes in government regulations and funding policies could impact Covista's revenue and profitability.

• Increased competition from other online education providers could lead to pricing pressures and reduced market share.
• Economic downturns could affect student enrollment and tuition revenue.
• Cybersecurity threats and data breaches could damage Covista's reputation and result in financial losses.
• Negative publicity related to student outcomes or program quality could impact enrollment and brand image.

What Are the Growth Opportunities for CVSA?

• Expansion of Online Program Offerings: Covista has the opportunity to expand its online program offerings to cater to a broader range of students and professionals. By introducing new programs in emerging fields such as data science, artificial intelligence, and cybersecurity, Covista can attract a new segment of students and increase its market share. This expansion can be achieved through strategic partnerships with industry leaders and investments in innovative learning technologies. Timeline: 2026-2028.
• Strategic Partnerships with Healthcare Institutions: Covista can strengthen its position in the healthcare education market by forming strategic partnerships with leading healthcare institutions. These partnerships can provide students with valuable clinical experience and job placement opportunities. The demand for healthcare professionals is expected to grow significantly in the coming years, driven by an aging population and advancements in medical technology. By collaborating with hospitals, clinics, and other healthcare providers, Covista can ensure that its graduates are well-prepared to meet the evolving needs of the healthcare industry. Timeline: Ongoing.
• Geographic Expansion into Emerging Markets: Covista can explore opportunities for geographic expansion into emerging markets with a growing demand for higher education. Countries in Asia, Africa, and Latin America are experiencing rapid economic growth and a rising middle class, leading to increased demand for quality education. By establishing a presence in these markets, Covista can tap into a new pool of students and diversify its revenue streams. This expansion can be achieved through partnerships with local institutions and the development of culturally relevant programs. Timeline: 2027-2030.
• Investment in Innovative Learning Technologies: Covista can enhance its educational offerings by investing in innovative learning technologies such as artificial intelligence, virtual reality, and augmented reality. These technologies can provide students with personalized learning experiences and improve learning outcomes. The market for educational technology is projected to reach $404 billion by 2026, presenting a significant opportunity for Covista to differentiate itself from its competitors. By integrating these technologies into its programs, Covista can attract tech-savvy students and enhance its reputation as a leader in educational innovation. Timeline: Ongoing.
• Development of Stackable Credentials and Micro-credentials: Covista can cater to the needs of working professionals by developing stackable credentials and micro-credentials that provide targeted skills and knowledge. These credentials can be earned in a shorter amount of time and can be stacked together to form a degree or certificate. The demand for micro-credentials is growing rapidly, as employers increasingly value specific skills and competencies. By offering these credentials, Covista can attract a new segment of students who are looking to upskill or reskill quickly. This can be achieved through partnerships with industry experts and the development of competency-based assessments. Timeline: 2026-2028.

What Are CVSA's Competitive Advantages?

• Strong brand reputation in the nursing and healthcare education market.
• Extensive network of healthcare partners providing clinical experience and job opportunities.
• Focus on high-demand fields with strong career prospects for graduates.

What Does CVSA Do?

Covista Inc., formerly known as Adtalem Global Education, was founded in 1973 by Dennis J. Keller and Ronald L. Taylor. Headquartered in Chicago, Illinois, the company has evolved into a prominent provider of post-secondary education. Covista operates through three main segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in nursing and health professions. The Walden segment provides online certificates, bachelor's, master's, and doctoral degrees in fields such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary segment focuses on degree and non-degree programs in the medical and veterinary postsecondary education industry. Covista's mission is to empower students and professionals to achieve their educational and career goals through accessible and innovative learning experiences. With a workforce of 10,371 employees, Covista continues to expand its reach and impact in the education sector.

What Products and Services Does CVSA Offer?

• Provides post-secondary education in nursing and health professions through the Chamberlain segment.
• Offers online certificates, bachelor's, master's, and doctoral degrees through the Walden segment.
• Delivers degree and non-degree programs in the medical and veterinary fields through the Medical and Veterinary segment.
• Focuses on high-demand fields such as nursing, healthcare, and education.
• Offers flexible learning options through online and hybrid programs.
• Partners with healthcare institutions to provide clinical experience and job placement opportunities.

How Does CVSA Make Money?

• Generates revenue through tuition fees from students enrolled in its various programs.
• Offers a range of degree and non-degree programs to cater to different student needs.
• Focuses on high-demand fields to ensure strong enrollment and career outcomes for graduates.

What Industry Does CVSA Operate In?

Covista Inc. operates in the consumer cyclical sector, specifically within the personal products and services industry, which includes post-secondary education. The market for online education is experiencing significant growth, driven by increasing demand for flexible learning options and the rising cost of traditional education. The competitive landscape includes both traditional universities and other for-profit education providers. Covista's focus on high-demand fields like nursing and healthcare positions it favorably within this market. The company's ability to adapt to changing student needs and technological advancements will be crucial for maintaining its competitive edge.

Who Are CVSA's Key Customers?

• Students seeking degrees and certificates in nursing and health professions.
• Working professionals looking to advance their careers through online education.
• Healthcare institutions seeking qualified graduates to fill critical roles.

Covista Inc. (CVSA) Valuation Context

Valued at $4.21B, CVSA is classified as a mid-cap stock. Analyst price targets span from $140.00 to $175.00, with a consensus of $157.50. At the current price of $123.63, that implies approximately 27% upside potential. Relative to its peer group, CVSA's quantitative score of 89/100 is above the peer average of 76/100.

CVSA Revenue & Earnings Trend

In Q4 FY2026, CVSA generated $501.4M in top-line revenue, marking a sequential increase of 2.9%. The company recorded net income of $71.7M, with diluted EPS of $2.06. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Consumer Cyclical. Across the four most recent quarters, CVSA averaged $1.76 in diluted EPS.

Company Profile

Covista Inc. operates in the Education & Training Services industry within the Consumer Defensive sector. It is headquartered in Chicago, US. The company is led by CEO Stephen W. Beard. CVSA has traded publicly since 2026.

Return on equity for Covista Inc. stands at 16.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 8.6%, showing how much profit it generates from its asset base. CVSA trades at a trailing price-to-earnings ratio of 16.37, below the Consumer Cyclical sector average of ~32.70x. Its free cash flow yield is 7.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.70 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 5.5%, the inverse of the P/E and a quick read on earnings relative to price.

Covista Inc.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.15 places it in the safe zone, indicating low near-term bankruptcy risk.

Covista Inc. has beaten Wall Street's EPS estimate in 8 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 14.7% above estimates on average.

Over the past six months, Covista Inc. insiders filed 28 SEC Form 4 transactions — 18 sales and 10 purchases. On net that is roughly 75K shares acquired (about $10.3M) — insiders putting money in tends to read as conviction.

CVSA Financials

CVSA Latest News

CVSA Analyst Consensus

CVSA MoonshotScore

Latest Covista Inc. Analysis

Covista Inc. Consumer Cyclical Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources